Skip to main content

Table 2 Clinic outcome scores: change from baseline during rTMS treatment for overall study population

From: Sleep quality improves during treatment with repetitive transcranial magnetic stimulation (rTMS) in patients with cocaine use disorder: a retrospective observational study

 

Baseline

Day 5

Day 30

Day 60

Day 90

PSQIa

9.24 (3.89)

5.09 (3.33)

5 (3.13)

5.28 (3.47)

6.12 (3.32)

Change from Baseline

 

−4.15 (0.53) *

−4.24 (0.58) *

−3.96 (0.67) *

−3.12 (0.66) *

CCQb

12.67 (10.93)

2.21 (3.29)

1.34 (2.79)

1.84 (4)

3.8 (6.5)

Change from Baseline

 

−10.45 (1.15) *

−11.32 (1.20) *

− 10.81 (1.41) *

−8.86 (1.38) *

BDI-IIc

18.99 (9.91)

-§

5.09 (6.45)

5.33 (7.67)

6.72 (7.2)

Change from Baseline

  

−13.89 (1.38) *

−13.65 (1.64) *

− 12.26 (1.58) *

SASd

47.93 (10.01)

36.11 (8.45)

35.97 (9.44)

35.33 (9.52)

38.09 (7.38)

Change from Baseline

 

−11.81 (2.04) *

−11.96 (1.54) *

−12.60 (1.87) *

−9.83 (1.77) *

GSIe

65.91 (16.53)

46.69 (12.17)

47.67 (14.46)

44.49 (10.92)

46.46 (9.56)

Change from Baseline

 

−19.22 (2.08) *

−18.24 (2.25) *

−21.42 (2.67) *

−19.45 (2.59) *

  1. Data are presented as Mean (SD);
  2. * p value <.001; § BDI-II was not administered at day 5 because it refers to the last 2 weeks;
  3. a Pittsburgh Sleep Quality Inventory – general sleep quality index; b Cocaine Craving Questionnaire; c Beck Depression Inventory – II; d Self-rating Anxiety Scale;
  4. e Global Severity Index from Symptoms Checklist – 90 – Revised